Medopad

Series B

London, UKFounded 2011Oct 2019

Medopad raised €23M in a Series B round in Oct 2019. The company is based in London, UK. Investors in the round: Bayer. Data as of Nov 2026.

Amount raised

€23M

€22,500,000

Native amount

22,500,000 EUR

Stage

Series B

series b

Investors

Provenance & confidence

High confidence

Amount

Reported in EUR — no conversion. €23M

High confidence

Source

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

1 named

Date

Oct 2019

Round type

series b

Amount (EUR)

€23M

same company